PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
6469209-3	1984	The inhibitory effect of 2-methylaminoethanol was selective for phospholipids methylation since protein carboxymethyltransferase and catechol-o-methyltransferase activities were not affected.	N-methylaminoethanol	25-45	catechol-O-methyltransferase	Rattus norvegicus	133-161
19590775-1	2009	The first step of the base-promoted decomposition of N-chloro,N-methylethanolamine in aqueous solution (CH3N(Cl)CH2CH2OH + HO- --> imine + Cl- + H2O (+ CH2O) --> amine + aldehyde) is investigated at the MP2/6-31++G(d,p) computing level.	N-methylaminoethanol	62-82	tryptase pseudogene 1	Homo sapiens	209-212
6320875-1	1984	Growth of C-6 glial cells in media enriched in the polar headgroup precursors N,N-dimethylethanolamine, N-monomethylethanolamine or ethanolamine for 24 h resulted in the accumulation of the corresponding phospholipids to about 30% of total membrane phospholipid.	N-methylaminoethanol	104-128	complement C6	Homo sapiens	10-13
24728967-7	2014	The activity of PLD and PLD1, alpha-SMA expression level in the MEA-intervention group was much lower than those in the DMN model group.	N-methylaminoethanol	64-67	phospholipase D1	Rattus norvegicus	24-28
7171591-12	1982	Half of the newly synthesized IgG1 acquired resistance to endoglycosidase H after 30-45 min, 1-1.5 h and 2-3 h in choline-, dimethylethanolamine- and monomethylethanolamine-supplemented cells, respectively.	N-methylaminoethanol	150-172	LOC105243590	Mus musculus	30-34
7171591-13	1982	Thus, the transport of IgG1 was markedly retarded by the modification with choline analogues, dimethylethanolamine or monomethylethanolamine, at least in the following two processes, from the rough endoplasmic reticulum to the Golgi complex and from the Golgi to the outside of cells.	N-methylaminoethanol	118-140	LOC105243590	Mus musculus	23-27
7171591-14	1982	Modification with monomethylethanolamine was more effective than that with dimethylethanolamine in slowing down the transport of IgG1 and appeared to cause accumulation of IgG1 within the cells.	N-methylaminoethanol	18-40	LOC105243590	Mus musculus	129-133
7171591-14	1982	Modification with monomethylethanolamine was more effective than that with dimethylethanolamine in slowing down the transport of IgG1 and appeared to cause accumulation of IgG1 within the cells.	N-methylaminoethanol	18-40	LOC105243590	Mus musculus	172-176
13184360-0	1954	The utilization by vitamin B12-deficient chicks of monomethylaminoethanol, homocystine and betaine as precursors of choline and methionine.	N-methylaminoethanol	51-73	NADH:ubiquinone oxidoreductase subunit B3	Homo sapiens	27-30
15246640-0	2004	N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism.	N-methylaminoethanol	0-20	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	96-111
15246640-2	2004	Since ethanolamine is a product of PLD, we hypothesised that an administration of an analogue of ethanolamine, N-methylethanolamine (MEA), decreases PLD activity through a negative feedback mechanism, suppresses collagen accumulation, and thus prevents organ dysfunction.	N-methylaminoethanol	111-131	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	35-38
15246640-2	2004	Since ethanolamine is a product of PLD, we hypothesised that an administration of an analogue of ethanolamine, N-methylethanolamine (MEA), decreases PLD activity through a negative feedback mechanism, suppresses collagen accumulation, and thus prevents organ dysfunction.	N-methylaminoethanol	111-131	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	149-152
15246640-2	2004	Since ethanolamine is a product of PLD, we hypothesised that an administration of an analogue of ethanolamine, N-methylethanolamine (MEA), decreases PLD activity through a negative feedback mechanism, suppresses collagen accumulation, and thus prevents organ dysfunction.	N-methylaminoethanol	133-136	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	35-38
15246640-2	2004	Since ethanolamine is a product of PLD, we hypothesised that an administration of an analogue of ethanolamine, N-methylethanolamine (MEA), decreases PLD activity through a negative feedback mechanism, suppresses collagen accumulation, and thus prevents organ dysfunction.	N-methylaminoethanol	133-136	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	149-152
8641441-2	1996	Ethanolamine and monomethylethanolamine alone had no effects on DNA synthesis, but they also enhanced the stimulatory effect of insulin, although less effectively than dimethylethanolamine did.	N-methylaminoethanol	17-39	insulin	Homo sapiens	128-135
9565615-6	1998	Treatment of cells with monomethylethanolamine or dithiothreitol decreased the translocation of apolipoprotein B and increased the proportion of ubiquitin-conjugated molecules associated with Sec61.	N-methylaminoethanol	24-46	apolipoprotein B	Homo sapiens	96-112
9565615-6	1998	Treatment of cells with monomethylethanolamine or dithiothreitol decreased the translocation of apolipoprotein B and increased the proportion of ubiquitin-conjugated molecules associated with Sec61.	N-methylaminoethanol	24-46	SEC61 translocon subunit alpha 1	Homo sapiens	192-197
8978481-0	1996	Monomethylethanolamine reduces plasma triacylglycerols and apolipoprotein B and increases apolipoprotein A-I rats without induction of fatty liver.	N-methylaminoethanol	0-22	apolipoprotein B	Rattus norvegicus	59-75
8978481-0	1996	Monomethylethanolamine reduces plasma triacylglycerols and apolipoprotein B and increases apolipoprotein A-I rats without induction of fatty liver.	N-methylaminoethanol	0-22	apolipoprotein A1	Rattus norvegicus	90-108
8978481-1	1996	Monomethylethanolamine (MME) inhibits very low density lipoprotein (VLDL) secretion from cultured rat hepatocytes by disruption of translocation of apolipoprotein (apo) B across the endoplasmic reticulum membrane (A. E. Rusinol, E. Y. W. Chan and J. E. Vance.	N-methylaminoethanol	0-22	apolipoprotein B	Rattus norvegicus	148-170
8978481-1	1996	Monomethylethanolamine (MME) inhibits very low density lipoprotein (VLDL) secretion from cultured rat hepatocytes by disruption of translocation of apolipoprotein (apo) B across the endoplasmic reticulum membrane (A. E. Rusinol, E. Y. W. Chan and J. E. Vance.	N-methylaminoethanol	24-27	apolipoprotein B	Rattus norvegicus	148-170
1892886-11	1991	Supplementation of the medium with monomethylethanolamine resulted in a 2-fold increase in labeled GPC, with a concomitant decrease of [3H]lysoPC by approx.	N-methylaminoethanol	35-57	glycophorin C	Rattus norvegicus	99-102
1847919-7	1991	The EPT1 gene product utilized CDP-ethanolamine, -monomethylethanolamine, -dimethylethanolamine, and -choline to significant extents, while the CPT1 gene product manifested relative specificity for CDP-choline and -dimethylethanolamine.	N-methylaminoethanol	49-72	bifunctional diacylglycerol cholinephosphotransferase/ethanolaminephosphotransferase	Saccharomyces cerevisiae S288C	4-8